• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Higher cardiovascular mortality in low- and middle-income countries [PURE study]

August 28, 2014
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
Successful regional implementation of pediatric chest pain algorithm
Share on FacebookShare on TwitterShare on LinkedIn

1. Although the burden of cardiovascular risk factors was highest in high-income countries, the rate of major cardiovascular events was significantly greater in low- and middle-income countries. 

2. This is likely due to greater access to preventive therapies and control of risk factors in high-income countries. 

Evidence Rating Level: 2 (Good)

Study Rundown: The Prospective Urban Rural Epidemiologic (PURE) study investigated the global burden of noncommunicable diseases and involved over 150,000 participants from 17 low-, middle-, and high-income countries. Findings from the study on cardiovascular risk and the incidence of cardiovascular events were published in this article. The study found that the burden of cardiovascular risk factors was highest in high-income countries yet the rate of major cardiovascular events was lowest in these countries. Meanwhile, the rate of non-major cardiovascular events was highest in high-income countries. This trend could be explained by greater access to preventive therapies and higher educational levels in high-income countries. A strength of the study is the inclusion of both urban and rural communities as well as countries of varied socioeconomic levels. Limitations of the study include lower follow-up rates in urban communities of low-income countries and limited detection of events in low-income countries compared to high-income countries due to differences in access to health care facilities.

Click to read the study, published today in NEJM

Relevant Reading: Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART modifiable risk score

RELATED REPORTS

Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

In-Depth [prospective cohort]: This study included 156,424 adults from 628 urban and rural communities in 17 countries. Data was collected on major cardiovascular events (death from cardiovascular causes and nonfatal stroke, myocardial infarction, and heart failure) and nonmajor cardiovascular events (all other cardiovascular events that led to hospitalization). Risk-factor burden was calculated using the validated INTERHEART Risk Score. A score of 0 to 48 was assigned with higher scores indicating greater burden.

The high-income countries recorded the highest mean INTERHEART Risk Score of 12.89 compared to middle- and low-income countries which had mean scores of 10.47 and 8.28, respectively (P<0.001). The use of antiplatelet drugs was highest in high-income countries, intermediate in middle-income countries, and lowest in low-income countries. The same pattern held true for the use of beta-blockers, renin-angiotensin system blockers, statins, and coronary revascularization. Over a mean follow-up of 4.1 years, there were 3900 deaths. The rate of major cardiovascular events was lowest in high-income countries, intermediate in middle-income countries, and highest in low-income countries (P<0.001). This pattern was reversed for the rate of nonmajor cardiovascular events with the highest rate occurring in high-income countries and the lowest rate in low-income countries (P<0.001).

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: cardiovascular disease
Previous Post

Low transmission in household contacts of patients with MERS-CoV

Next Post

Collaborative care model reduces depression in lung cancer patients [SMaRT Oncology-3 Trial]

RelatedReports

A man walking along a path surrounded by healthy food options, sporting shoes, a heart illustration, and urban scenery, indicating lifestyle changes for cardiovascular health.
Cardiology

Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status

October 22, 2026
Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

September 3, 2026
Jessica Lau
Psychiatry

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

September 4, 2026
Next Post
Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]

Collaborative care model reduces depression in lung cancer patients [SMaRT Oncology-3 Trial]

High dose antidepressants may increase self-harm risk among children, young adults

Most cancer patients may not receive adequate treatment for comorbid depression

Damage similar in each eye after sequential ischemic optic neuropathy

Damage similar in each eye after sequential ischemic optic neuropathy

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.